Zoledronic Acid Injection, Solution
Product Images NDC 68083-672

This is a description of a medication with the NDC 68083-672-01, Zoledronic Acid Injection, with a concentration of 4 mg per 100 mL. It is for intravenous infusion with a minimum infusion time of 15 minutes and should not be mixed with calcium-containing solutions. The product is not for patients with reduced renal function and is for single-dose use only. Each 100 mL bag contains zoledronic acid monohydrate, sodium chloride, mannitol, and sodium citrate. The storage conditions are specified, and the product is sterile, non-pyrogenic, preservative-free, DEHP-free, and PVC-free. The container is latex-free and manufactured by GLAND PHARMA LIMITED in Hyderabad, India.*

This text contains information about a medication called Zoledronic Acid Injection. It comes in a 100 mL bag with a concentration of 4 mg per 100 mL (0.04 mg per mL) for intravenous infusion. The infusion time should not be less than 15 minutes, and it is not suitable for patients with reduced renal function. The product is for single-dose use only, and any unused portion should be discarded.*

This text contains important information about a Zoledronic Acid Injection with a concentration of 4 mg per 100 mL. It is intended for intravenous infusion and should not be mixed with calcium-containing solutions. The infusion time should not exceed 16 minutes. The solution is designed for patients with reduced renal function and is for single-dose use only. The container holds 426.4 mg of zoledronic acid monohydrate per 100 mL. The storage instructions recommend keeping it between 20°C to 25°C. The solution is nonpyrogenic and preservative-free. Check for leaks before use and ensure both the solution and container are undamaged.*